SG Americas Securities LLC Has $267,000 Stock Position in Orthofix Medical Inc. (NASDAQ:OFIX)

SG Americas Securities LLC boosted its stake in shares of Orthofix Medical Inc. (NASDAQ:OFIX) by 74.0% during the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 17,117 shares of the medical device company’s stock after buying an additional 7,278 shares during the period. SG Americas Securities LLC’s holdings in Orthofix Medical were worth $267,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. nVerses Capital LLC acquired a new stake in shares of Orthofix Medical in the second quarter valued at approximately $27,000. Quest Partners LLC acquired a new stake in shares of Orthofix Medical in the second quarter valued at approximately $64,000. Zurcher Kantonalbank Zurich Cantonalbank raised its holdings in shares of Orthofix Medical by 25.5% in the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 9,435 shares of the medical device company’s stock valued at $125,000 after purchasing an additional 1,919 shares during the last quarter. Arizona State Retirement System acquired a new stake in shares of Orthofix Medical in the second quarter valued at approximately $139,000. Finally, XTX Topco Ltd acquired a new stake in shares of Orthofix Medical in the second quarter valued at approximately $175,000. 89.76% of the stock is currently owned by institutional investors and hedge funds.

Orthofix Medical Price Performance

NASDAQ OFIX opened at $16.05 on Monday. The company has a quick ratio of 1.13, a current ratio of 2.48 and a debt-to-equity ratio of 0.24. Orthofix Medical Inc. has a 12-month low of $9.57 and a 12-month high of $17.67. The company has a market capitalization of $612.63 million, a PE ratio of -5.03 and a beta of 1.05. The firm’s 50 day moving average is $16.18 and its 200-day moving average is $14.94.

Orthofix Medical (NASDAQ:OFIX) last released its earnings results on Tuesday, August 6th. The medical device company reported ($0.88) earnings per share for the quarter, missing the consensus estimate of ($0.30) by ($0.58). Orthofix Medical had a negative net margin of 15.61% and a negative return on equity of 20.68%. The firm had revenue of $198.62 million during the quarter, compared to the consensus estimate of $195.75 million. Equities research analysts anticipate that Orthofix Medical Inc. will post -2.13 earnings per share for the current fiscal year.

Orthofix Medical Company Profile

Orthofix Medical Inc operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions.